يعرض 1 - 10 نتائج من 26 نتيجة بحث عن '"Gallium-68"', وقت الاستعلام: 0.95s تنقيح النتائج
  1. 1

    المساهمون: İÜC, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

    المصدر: Molecular Imaging and Radionuclide Therapy
    Molecular Imaging and Radionuclide Therapy, Vol 28, Iss 3, Pp 104-111 (2019)

    وصف الملف: application/pdf

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    المساهمون: Bursa Uludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı., Kurt, Meral, FFQ-3211-2022

    مصطلحات موضوعية: Male, Survival rate, Positron emission tomography-computed tomography, Kaplan Meier method, medicine.medical_treatment, Gallium, Intensity modulated radiation therapy, Procedures, Metastasis, Radiology, nuclear medicine & medical imaging, 0302 clinical medicine, Prostate, Antineoplastic agents, Radiation injuries, Treatment outcome, Oligometastasis, Multicenter study, Clinical trial, Retrospective study, Oncology, Antineoplastic agent, Stereotactic body radiation therapy, 030220 oncology & carcinogenesis, Diagnostic imaging, Prostate tumor, Human, Diarrhea, medicine.medical_specialty, PSMA PET, Major clinical study, Adenocarcinoma, Radiosurgery, Article, 03 medical and health sciences, Membrane antigen, Humans, Multimodality cancer therapy, Compression fracture, Survival analysis, Cancer recurrence, Aged, Curative treatment, Positron emission tomography computed tomography, Very elderly, Follow up, Kaplan-meier estimate, medicine.disease, Acute toxicity, Radiation therapy, Retrospective studies, Clinical effectiveness, Gallium 68, Radiopharmaceuticals, Prostate specific membrane antigen, Survival, Stereotactic body radiotherapy, Aged, 80 and over, antigens, surface, Gallium radioisotopes, Cancer staging, 030218 nuclear medicine & medical imaging, Prostate cancer, Fluoromethylcholine, Fluciclovine F-18, Choline, Recurrence, Prostate adenocarcinoma, Recurrent disease, Overall survival, Middle aged, FOLH1 protein, human, medicine.diagnostic_test, Radiation dose, Gallium-68, Progression-free survival, Combined modality therapy, Nausea, Gastrointestinal disease, medicine.anatomical_structure, Toxicity, Trend study, Dose fractionation, radiation, Radiology, Prostatic neoplasms, Adult, Adverse event, PET/CT, Follow-up studies, Dizziness, Radiotherapy, intensity-modulated, Glutamate carboxypeptidase II, Biopsy, medicine, Radiology, Nuclear Medicine and imaging, Radiopharmaceutical agent, Radiation injury, Gastrointestinal diseases, business.industry, Medical society, Progression free survival, Therapy, business

  8. 8

    المساهمون: Nuclear Oncology (CRCINA-ÉQUIPE 13), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Service de Radiologie [Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), Département de Pathologie [CHU Nantes], Unité de Pharmacie [ICO, Saint Herblain], Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER-UNICANCER, Délégation à la Recherche Clinique et à l'Enovation [Nantes] ((DRCI)), Hôtel-Dieu-Centre hospitalier universitaire de Nantes (CHU Nantes), Immunomedics Inc. [Morris Plains, NJ, USA], IBC Pharmaceuticals Inc [Morris Plains, NJ, USA], ARRONAX - (GIP) Groupement d'Intérêt Public [Saint-Herblain] (Institut de Recherche Public), Bernardo, Elizabeth, Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)

    المصدر: European Journal of Nuclear Medicine and Molecular Imaging
    European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2021, 48, pp.874-882. ⟨10.1007/s00259-020-04989-3⟩
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48, pp.874-882. ⟨10.1007/s00259-020-04989-3⟩

    وصف الملف: application/pdf

  9. 9
  10. 10